389 related articles for article (PubMed ID: 33657988)
21. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis.
Rahimi R; Nikfar S; Abdollahi M
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):118-27. PubMed ID: 19028540
[TBL] [Abstract][Full Text] [Related]
22. Research on the signaling pathways related to the intervention of traditional Chinese medicine in Parkinson's disease:A literature review.
Jin X; Dong W; Chang K; Yan Y
J Ethnopharmacol; 2024 May; 326():117850. PubMed ID: 38331124
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis.
Mills KA; Greene MC; Dezube R; Goodson C; Karmarkar T; Pontone GM
Int J Geriatr Psychiatry; 2018 Apr; 33(4):642-651. PubMed ID: 29235150
[TBL] [Abstract][Full Text] [Related]
24. Safety and Efficacy of SSRIs in Improving Poststroke Recovery: A Systematic Review and Meta-Analysis.
Kalbouneh HM; Toubasi AA; Albustanji FH; Obaid YY; Al-Harasis LM
J Am Heart Assoc; 2022 Jul; 11(13):e025868. PubMed ID: 35730636
[TBL] [Abstract][Full Text] [Related]
25. Traditional Chinese medicine treatment for COVID-19: An overview of systematic reviews and meta-analyses.
Wu HT; Ji CH; Dai RC; Hei PJ; Liang J; Wu XQ; Li QS; Yang JC; Mao W; Guo Q
J Integr Med; 2022 Sep; 20(5):416-426. PubMed ID: 35811240
[TBL] [Abstract][Full Text] [Related]
26. Rapid Onset of the Effects of Combined Selective Serotonin Reuptake Inhibitors and Electroacupuncture on Primary Depression: A Meta-Analysis.
Zhang Y; Qu SS; Zhang JP; Sun YL; Liu WL; Xie L; Huang Y; Chen JQ
J Altern Complement Med; 2016 Jan; 22(1):1-8. PubMed ID: 26655087
[TBL] [Abstract][Full Text] [Related]
27. Comparative risk of Selective Serotonin Reuptake Inhibitors (SSRIs)-induced nausea among Chinese senile depression patients: A network meta-analysis of randomized-controlled trials.
Guo S; Yang Y; Pei XJ; Liu FY
Medicine (Baltimore); 2020 Feb; 99(7):e19133. PubMed ID: 32049832
[TBL] [Abstract][Full Text] [Related]
28. Tolerability of paroxetine in Parkinson's disease: a prospective study.
Tesei S; Antonini A; Canesi M; Zecchinelli A; Mariani CB; Pezzoli G
Mov Disord; 2000 Sep; 15(5):986-9. PubMed ID: 11009210
[TBL] [Abstract][Full Text] [Related]
29. Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors as adjuncts for postoperative pain management: systematic review and meta-analysis of randomised controlled trials.
Wang L; Tobe J; Au E; Tran C; Jomy J; Oparin Y; Couban RJ; Paul J
Br J Anaesth; 2022 Jan; 128(1):118-134. PubMed ID: 34756632
[TBL] [Abstract][Full Text] [Related]
30. Evaluation on the efficacy and safety of Chinese herbal medication Xifeng Dingchan Pill in treating Parkinson's disease: study protocol of a multicenter, open-label, randomized active-controlled trial.
Zhang J; Ma YZ; Shen XM
J Integr Med; 2013 Jul; 11(4):285-90. PubMed ID: 23867247
[TBL] [Abstract][Full Text] [Related]
31. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
[TBL] [Abstract][Full Text] [Related]
32. A systematic review of integrated traditional Chinese and Western medicine for managing irritable bowel syndrome.
Li CY; Ain Mohd Tahir N; Li SC
Am J Chin Med; 2015; 43(3):385-406. PubMed ID: 25916468
[TBL] [Abstract][Full Text] [Related]
33. A systematic review of Chinese randomized clinical trials of SSRI treatment of depression.
Zhang Y; Becker T; Ma Y; Koesters M
BMC Psychiatry; 2014 Aug; 14():245. PubMed ID: 25159460
[TBL] [Abstract][Full Text] [Related]
34. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
35. Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports.
Takahashi H; Kamata M; Yoshida K; Higuchi H; Shimizu T
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):351-3. PubMed ID: 15694247
[TBL] [Abstract][Full Text] [Related]
36. Managing Depression with
Yang L; Shergis JL; Di YM; Zhang AL; Lu C; Guo X; Fang Z; Xue CC; Li Y
J Altern Complement Med; 2020 Jan; 26(1):8-24. PubMed ID: 31328996
[No Abstract] [Full Text] [Related]
37. Examining patterns of traditional Chinese medicine use in pediatric oncology: A systematic review, meta-analysis and data-mining study.
Lam CS; Peng LW; Yang LS; Chou HWJ; Li CK; Zuo Z; Koon HK; Cheung YT
J Integr Med; 2022 Sep; 20(5):402-415. PubMed ID: 35750623
[TBL] [Abstract][Full Text] [Related]
38. [Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis].
Liu HM; Wang XB; Chang YJ; Gu LL
Zhong Xi Yi Jie He Xue Bao; 2012 Nov; 10(11):1211-28. PubMed ID: 23158939
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of Selective Serotonin Reuptake Inhibitors (SSRIs) Compared to Tricyclic Antidepressants (TCAs) in the Efficacy and Safety of Anti-depression Therapy in Parkinson's Disease(PD) Patients.
Qiu BY; Qiao JX; Yong J
Iran J Pharm Res; 2014; 13(4):1213-9. PubMed ID: 25587309
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of oral traditional Chinese patent medicine in treatment of liver stagnation and spleen deficiency of depression: A protocol for systematic review.
Yu Y; Zhang G; Han T; Huang H
Medicine (Baltimore); 2020 Feb; 99(7):e19142. PubMed ID: 32049837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
